Evidence map›Paper›PMID 41074907›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2025

Development and evaluation of image preprocessing pipelines for the Centiloid method on Down Syndrome data.

Weiquan Luo, Davneet S Minhas, Ethan D Rubenstein, David N Situ, Sarah K Royse, Beau M Ances, Bradley T Christian, Ann D Cohen, Benjamin L Handen, William E Klunk and 4 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Development and evaluation of image preprocessing pipelines for the Centiloid method on Down Syndrome data.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Weiquan LuoDepartment of Bioengineering, University of Pittsburgh, Swanson School of Engineering, Pittsburgh, Pennsylvania, USA.
Davneet S MinhasDepartment of Radiology, University of Pittsburgh, PET Center, Presbyterian Hospital, Pittsburgh, Pennsylvania, USA.
Ethan D RubensteinSchool of Computing and Information, University of Pittsburgh, Information Sciences Building, Pittsburgh, Pennsylvania, USA.
David N SituDepartment of Bioengineering, University of Pittsburgh, Swanson School of Engineering, Pittsburgh, Pennsylvania, USA.
Sarah K RoyseDepartment of Radiology, University of Pittsburgh, PET Center, Presbyterian Hospital, Pittsburgh, Pennsylvania, USA.
Beau M AncesDepartment of Neurology, Washington University, St. Louis, Missouri, USA.
Bradley T ChristianDepartment of Psychiatry, Waisman Center, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Ann D CohenDepartment of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Benjamin L HandenDepartment of Psychiatry, University of Pittsburgh, Quantum Building, Pittsburgh, Pennsylvania, USA.
William E KlunkDepartment of Psychiatry, University of Pittsburgh, 1422 UPMC Western Psychiatric Hospital, Pittsburgh, Pennsylvania, USA.
Dana L TudorascuDepartment of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Shahid ZamanDepartment of Psychiatry, University of Cambridge, Douglas House, Cambridge, UK.
Charles M LaymonDepartment of Bioengineering, University of Pittsburgh, Swanson School of Engineering, Pittsburgh, Pennsylvania, USA.
Alzheimer's Biomarkers Consortium–Down Syndrome (ABC‐DS) Investigators

Funding

University of Pittsburgh Clinical and Translational Science InstituteUL1TR001857 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2016 to 2025
$129.3M
National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD)U24AG021886 · NIA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI TATIANA M. FOROUD · 2002 to 2026
$119.8M
Project 3: Biomarkers for DS Clinical TrialsU19AG068054 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ANCES, BEAU M · 2020 to 2025
$103.7M
Clinical and Translational Science AwardUL1TR001873 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI REILLY, MUREDACH P · 2016 to 2025
$99.0M
WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
University of Wisconsin Institute for Clinical and Translational ResearchUL1TR002373 · NCATS · UNIVERSITY OF WISCONSIN-MADISON · PI ELIZABETH S BURNSIDE, Allan R. Brasier · 2017 to 2026
$75.9M
WASHINGTON UNIVERSITY ALZHEIMERS DISEASE RESEARCH CENTERP50AG005681 · NIA · WASHINGTON UNIVERSITY · PI MORRIS, JOHN · 1985 to 2019
$52.1M
Satellite Diagnostic and Treatment Clinic CoreP50AG008702 · NIA · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI DE JAGER, PHILIP L · 1989 to 2019
$46.3M
RADx-UP: Improving the Response of Local Urban and Rural Communities to Disparities in Covid-19 TestingUL1TR002366 · NCATS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Mario Castro, JAMES STEVEN LEEDER · 2017 to 2026
$44.3M
TREATMENT OF DEPRESSION IN ALZHEIMER'S DISEASEP50AG005133 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SWEET, ROBERT A · 1985 to 2019
$43.0M
Research Education ComponentP30AG062421 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI Christine S Ritchie · 2019 to 2026
$36.5M
University of California Health Participation in the National COVID Cohort Collaborative (N3C)UL1TR001414 · NCATS · UNIVERSITY OF CALIFORNIA-IRVINE · PI COOPER, DAN M, VILAIN, ERIC J. · 2015 to 2023
$35.1M
Alzheimer's Disease Research Centers Program P50 AG16537DS-ConnectInvestigation of Co-occurring conditions across the Lifespan to Understand Down SyndromeNational Centralized Repository for Alzheimer Disease and Related Dementias U24 AG21886National Institute for Health and Care Research (NIHR) Cambridge Biomedical Research Centre NIHR203312NCATS NIH HHS UL1 TR001414NCATS NIH HHS UL1 TR001857NCATS NIH HHS UL1 TR001873NCATS NIH HHS UL1 TR002345NCATS NIH HHS UL1 TR002366NCATS NIH HHS UL1 TR002373NIA NIH HHS P30 AG062421NIA NIH HHS P30 AG062715NIA NIH HHS P30 AG066444NIA NIH HHS P30 AG066468NIA NIH HHS P30 AG066519NIA NIH HHS P30 AG072973NIA NIH HHS P50 AG005133NIA NIH HHS P50 AG005681NIA NIH HHS P50 AG008702NIA NIH HHS U01 AG051406NIA NIH HHS U01 AG051412NIA NIH HHS U19 AG068054NIA NIH HHS U24 AG021886NICHD NIH HHS P50 HD105353NIHR Applied Research Collaboration East of England
6 · The paper itself

Abstract

backgroundCentiloid provides a standardized process to quantify brain amyloid in which a subject's T1 magnetic resonance imaging (MRI) and amyloid positron emission tomography (PET) scans are registered and warped to Montreal Neurological Institute 152 space using prescribed procedures. The method has a high failure rate in Down syndrome (DS) subjects from the Neurodegeneration in Aging Down Syndrome (NiAD) project. We evaluate imaging preprocessing methods (PMs) to improve the DS success rate.

methodsPMs were constructed from combinations of image origin reset, filtering, MRI bias correction, and MRI skull stripping. Centiloid results were evaluated for adherence to standards using The Global Alzheimer's Association Interactive Network dataset. PMs were also evaluated using the NiAD dataset to judge their suitability for the DS population. DS PM evaluation procedures were developed corresponding to those specified for non-DS populations.

resultsFive accepted PMs improved the Centiloid-processing success rate in the DS cohort from 61.3% to 95.6%. DISCUSSION: The identified combinations of preprocessing steps substantially improved the success rate of Centiloid processing in DS. HIGHLIGHTS: Image preprocessing pipeline is proposed for Centiloid analysis of DS. Preprocessing pipelines are evaluated for adherence to Centiloid standards. Pipelines are evaluated for improvement in yield of usable imaging data. Preprocessing of amyloid imaging data resulted in a large yield improvement.

Indexed as

BrainDown SyndromeImage Processing, Computer-AssistedMagnetic Resonance ImagingFemaleHumansMaleMiddle AgedPositron-Emission Tomographyamyloid imagingCentiloidDown Syndromeimage processingMRIPET

Identifiers

PMID41074907
PMCPMC12514937

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.